Publication | Closed Access
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression
21
Citations
30
References
2012
Year
These results do not support a strong role of 8,12-iso-iPF2alpha-VI in the prediction of disease progression in MS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1